Catalyst Wire Dossier Catalyst Wire Dossier

Lutetium-177Lu chloride Billev

lutetium (177Lu) chloride · Billev Pharma Aps
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lutetium-177Lu chloride Billev, covering 2024-11-29 to 2024-11-29. Get the full timeline:

Most recent: EMA Authorised: Lutetium (177Lu) chloride Billev (previously Illuzyce) (lutetium (177Lu) chloride) — Billev Pharma Aps

See pricing